Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Alnylam Pharmaceuticals Inc (DUL.BE)

Berlin - Berlin Delayed Price. Currency in EUR
175.42+0.06 (+0.03%)
At close: 08:08PM CET
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,037,418
1,037,418
844,287
492,853
219,750
Cost of Revenue
168,817
168,817
140,144
78,052
25,062
Gross Profit
868,601
868,601
704,143
414,801
194,688
Operating Expense
1,653,673
1,653,673
1,412,795
1,243,239
1,134,119
Operating Income
-785,072
-785,072
-708,652
-828,438
-939,431
Net Non Operating Interest Income Expense
-131,160
-131,160
-141,442
-72,687
33,448
Other Income Expense
-210,761
-210,761
-2,050
45,525
20,730
Pretax Income
-1,126,993
-1,126,993
-852,144
-855,600
-885,253
Tax Provision
4,163
4,163
680
2,681
863
Net Income Common Stockholders
-1,131,156
-1,131,156
-852,824
-858,281
-886,116
Diluted NI Available to Com Stockholders
-1,131,156
-1,131,156
-852,824
-858,281
-886,116
Basic EPS
-
-9.30
-7.20
-7.46
-8.11
Diluted EPS
-
-9.30
-7.20
-7.46
-8.11
Basic Average Shares
-
121,689
118,451
114,986
109,264
Diluted Average Shares
-
121,689
118,451
114,986
109,264
Total Operating Income as Reported
-785,072
-785,072
-708,652
-828,438
-939,431
Rent Expense Supplemental
131,967
131,967
-
-
-
Total Expenses
1,822,490
1,822,490
1,552,939
1,321,291
1,159,181
Net Income from Continuing & Discontinued Operation
-1,131,156
-1,131,156
-852,824
-858,281
-886,116
Normalized Income
-1,008,422
-1,008,422
-865,425
-885,187
-886,116
Interest Income
24,808
24,808
1,579
11,809
33,448
Interest Expense
155,968
155,968
143,021
84,496
-
Net Interest Income
-131,160
-131,160
-141,442
-72,687
33,448
EBIT
-971,025
-971,025
-709,123
-771,104
-939,431
EBITDA
-885,475
-
-
-
-
Reconciled Cost of Revenue
168,817
168,817
140,144
78,052
25,062
Reconciled Depreciation
85,550
85,550
89,694
74,435
54,368
Net Income from Continuing Operation Net Minority Interest
-1,131,156
-1,131,156
-852,824
-858,281
-886,116
Total Unusual Items Excluding Goodwill
-204,557
-204,557
17,262
36,857
0
Total Unusual Items
-204,557
-204,557
17,262
36,857
0
Normalized EBITDA
-680,918
-680,918
-636,691
-733,526
-885,063
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-81,823
-81,823
4,661
9,951
0
Advertisement
Advertisement